title: Prediction of response of chronic depression to imipramine.
abstract: We had previously reported that imipramine was superior to placebo for the treatment of chronic depression. As a part of that study, we subsequently investigated clinical and demographic variables which might be associated with favorable or poor outcome for treatment with imipramine or placebo. Results are reported herein. Eight-six patients were entered and 53 completed an 8-week protocol. Outcome was assessed based on a 6-week, double-blind treatment phase, which followed a 2-week, single-blind placebo phase. Outcome was not found to significantly relate to demographic variables, severity or course of depression, diagnostic subtype, symptom profile, or DST results. Some modest associations were found between 'neurotic' personality traits and poor outcome. Results are discussed and compared with prior studies of prediction of tricyclic antidepressant response in both acute and chronic depressions.
authors.affiliation: Department of Psychiatry, New York Hospital-Cornell Medical Center, NY 10021.
authors.forename: J H
authors.initials: JH
authors.lastname: Kocsis
authors.forename: B J
authors.initials: BJ
authors.lastname: Mason
authors.forename: A J
authors.initials: AJ
authors.lastname: Frances
authors.forename: J
authors.initials: J
authors.lastname: Sweeney
authors.forename: J J
authors.initials: JJ
authors.lastname: Mann
authors.forename: D
authors.initials: D
authors.lastname: Marin
mesh_terms: D000328:Adult; D002908:Chronic Disease; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic
chemical_list: D007099:Imipramine